These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
4. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Hasegawa M; Hamaguchi Y; Yanaba K; Bouaziz JD; Uchida J; Fujimoto M; Matsushita T; Matsushita Y; Horikawa M; Komura K; Takehara K; Sato S; Tedder TF Am J Pathol; 2006 Sep; 169(3):954-66. PubMed ID: 16936269 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis. Sakkas LI; Chikanza IC; Platsoucas CD Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253 [TBL] [Abstract][Full Text] [Related]
6. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis. Hasegawa M J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836 [TBL] [Abstract][Full Text] [Related]
7. Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature. Daoussis D; Liossis SN; Tsamandas AC; Kalogeropoulou C; Kazantzi A; Korfiatis P; Yiannopoulos G; Andonopoulos AP Semin Arthritis Rheum; 2010 Oct; 40(2):127-36. PubMed ID: 20004954 [TBL] [Abstract][Full Text] [Related]
8. New developments in the pathogenesis of systemic sclerosis. Sakkas LI Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330 [TBL] [Abstract][Full Text] [Related]
9. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335 [TBL] [Abstract][Full Text] [Related]
11. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al. Hmida Y; Schmit P; Gilson G; Humbel RL Arthritis Rheum; 2002 Jan; 46(1):280-2. PubMed ID: 11817606 [No Abstract] [Full Text] [Related]
12. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma. Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. Hasegawa M; Fujimoto M; Takehara K; Sato S J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma). Kondo H; Rabin BS; Rodnan GP J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970 [TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a human B cell line from the lung tissue of a patient with scleroderma; extraordinary high level of IL-6 secretion by stimulated fibroblasts. Kondo K; Okada T; Matsui T; Kato S; Date K; Yoshihara M; Nagata Y; Takagi H; Yoneda M; Sugie I Cytokine; 2001 Feb; 13(4):220-6. PubMed ID: 11237429 [TBL] [Abstract][Full Text] [Related]
16. Circulating T and B lymphocytes in progressive systemic sclerosis. de Jesus DG; Clancy RL J Rheumatol; 1975 Sep; 2(3):336-9. PubMed ID: 1081143 [TBL] [Abstract][Full Text] [Related]
17. [In vitro reactivity of lymphocytes obtained from patients with diffuse scleroderma]. Onisk Z; Tchórzewski H Przegl Dermatol; 1975; 62(2):183-6. PubMed ID: 1079955 [No Abstract] [Full Text] [Related]
18. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse. Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201 [TBL] [Abstract][Full Text] [Related]